The Needle Syringe Program National Minimum Data Collection (NSP NMDC) supports the National Strategies for blood borne and sexually transmissible infections and complements the annual Australian Needle Syringe Program Survey National Data Report.
PBS-subsidised HIV pre-exposure prophylaxis from April 2018 to June 2020.
PBS-subsidised HIV pre-exposure prophylaxis from April 2018 to June 2019
The Needle Syringe Program National Minimum Data Collection (NSP NMDC) supports the National Strategies for blood borne and sexually transmissible infections and complements the annual Australian Needle Syringe Program Survey National Data Report.
The National Prison Entrants’ Blood Borne Virus Survey (NPEBBVS) was first conducted in 2004 to determine the prevalence of bloodborne viruses in Australian prisons and to examine risk factors associated with exposure. It aimed to provide information on prison entrants at risk of contracting bloodborne viruses as a result of injecting or other behaviours conducted prior to imprisonment. The first survey included New South Wales, Queensland, Western Australia and Tasmania.
PBS-subsidised HIV pre-exposure prophylaxis from April 2018 to December 2018.
All eight Australian jurisdictions operate a range of needle syringe program (NSP) services and collect data on NSP activity. The NSP NMDC reports aggregated jurisdictional data. Although there are common areas of data collection across all jurisdictions, there are varied levels of completeness and alignment for some agreed NSP NMDC data elements.
The NSP NMDC Data Dictionary provides guidelines and definitions for NSP specific data elements. The purpose of the NSP NMDC Data Dictionary is to provide a framework for the reporting of NSP NMDC data elements.
The Needle Syringe Program National Minimum Data Collection (NSP NMDC) supports the National Strategies for blood borne and sexually transmissible infections and complements the annual Australian Needle and Syringe Program (NSP) Survey National Data Report.
Prisoner populations are characterised by engagement in risk behaviours, most notably injecting drug use. Consequently they are at an increased risk of exposure to blood-borne viruses such as hepatitis B, hepatitis C and HIV. Previous Australian research has shown that hepatitis C is between thirty to forty times higher among prisoners compared with the general community. Surveillance of this population is important to monitor trends in the prevalence of blood-borne viruses and changes over time in risk behaviours.
